James Bilsborrow, a Weitz & Luxenberg partner and practice group co-chair, is speaking at a virtual event titled “PFAS Litigation and Regulatory Developments Conference.” It…
Read MoreFirm News: May 2007
Category: Mesothelioma
$37 Million for Lung Cancer
On Friday, May 11, 2007, Weitz & Luxenberg, P.C., a staunch protector of the rights of workers who have been recklessly exposed to asbestos, won Phase II of a reverse-bifurcated lung cancer trial against Robert A. Keasbey Company. The company was a former insulation contractor that also distributed asbestos products in the New York metropolitanā¦